169 related articles for article (PubMed ID: 31937347)
1. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebo-controlled, randomised, double blind, multi-centre study.
Tegtmeier F; Schinzel R; Beer R; Bulters D; LeFrant JY; Sahuquillo J; Unterberg A; Andrews P; Belli A; Ibanez J; Lagares A; Mokry M; Willschke H; Flüh C; Schmutzhard E;
Trials; 2020 Jan; 21(1):80. PubMed ID: 31937347
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide synthase inhibition with the antipterin VAS203 improves outcome in moderate and severe traumatic brain injury: a placebo-controlled randomized Phase IIa trial (NOSTRA).
Stover JF; Belli A; Boret H; Bulters D; Sahuquillo J; Schmutzhard E; Zavala E; Ungerstedt U; Schinzel R; Tegtmeier F;
J Neurotrauma; 2014 Oct; 31(19):1599-606. PubMed ID: 24831445
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial.
Nichol A; French C; Little L; Presneill J; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R;
Trials; 2015 Feb; 16():39. PubMed ID: 25884605
[TBL] [Abstract][Full Text] [Related]
4. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
[TBL] [Abstract][Full Text] [Related]
5. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
Mahmood A; Roberts I; Shakur H
Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
[TBL] [Abstract][Full Text] [Related]
6. Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.
Ott C; Bosch A; Winzer N; Friedrich S; Schinzel R; Tegtmeier F; Schmieder RE
Br J Clin Pharmacol; 2019 May; 85(5):900-907. PubMed ID: 30666700
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study.
Tegtmeier F; Schinzel R; Beer R; Bulters D; LeFrant JY; Sahuquillo J; Unterberg A; Andrews P; Belli A; Ibanez J; Lagares A; Mokry M; Willschke H; Flüh C; Schmutzhard E;
Trials; 2020 Feb; 21(1):172. PubMed ID: 32051020
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
Maas AI; Murray G; Henney H; Kassem N; Legrand V; Mangelus M; Muizelaar JP; Stocchetti N; Knoller N;
Lancet Neurol; 2006 Jan; 5(1):38-45. PubMed ID: 16361021
[TBL] [Abstract][Full Text] [Related]
9. Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial.
Presneill J; Gantner D; Nichol A; McArthur C; Forbes A; Kasza J; Trapani T; Murray L; Bernard S; Cameron P; Capellier G; Huet O; Newby L; Rashford S; Rosenfeld JV; Smith T; Stephenson M; Varma D; Vallance S; Walker T; Webb S; James Cooper D;
Trials; 2018 Apr; 19(1):259. PubMed ID: 29703266
[TBL] [Abstract][Full Text] [Related]
10. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
CRASH-3 trial collaborators
Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
[TBL] [Abstract][Full Text] [Related]
11. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
12. Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial.
Wu X; Zhang C; Feng J; Mao Q; Gao G; Jiang J
Trials; 2017 Jul; 18(1):311. PubMed ID: 28693604
[TBL] [Abstract][Full Text] [Related]
13. Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children.
Clark RSB; Empey PE; Bayır H; Rosario BL; Poloyac SM; Kochanek PM; Nolin TD; Au AK; Horvat CM; Wisniewski SR; Bell MJ
PLoS One; 2017; 12(7):e0180280. PubMed ID: 28686657
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of electro-acupuncture treatment in improving the consciousness of patients with traumatic brain injury: study protocol for a randomized controlled trial.
Liu J; Xue X; Wu Y; Yang C; Li N; Li H
Trials; 2018 May; 19(1):296. PubMed ID: 29843761
[TBL] [Abstract][Full Text] [Related]
15. Protocol for Safety and Efficacy of MLC901 (NeuroAiD II) in Patients With Moderate Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Trial (ANDROMEDA).
Chua AE; Yacapin VJ; Manalo GL; Ledesma LK
Neurosurgery; 2023 Oct; 93(4):939-951. PubMed ID: 37129384
[TBL] [Abstract][Full Text] [Related]
16. Effects of Oral Glibenclamide on Brain Contusion Volume and Functional Outcome of Patients with Moderate and Severe Traumatic Brain Injuries: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Khalili H; Derakhshan N; Niakan A; Ghaffarpasand F; Salehi M; Eshraghian H; Shakibafard A; Zahabi B
World Neurosurg; 2017 May; 101():130-136. PubMed ID: 28185976
[TBL] [Abstract][Full Text] [Related]
17. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group.
Marmarou A; Nichols J; Burgess J; Newell D; Troha J; Burnham D; Pitts L
J Neurotrauma; 1999 Jun; 16(6):431-44. PubMed ID: 10391361
[TBL] [Abstract][Full Text] [Related]
18. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.
van Erp IAM; van Essen TA; Fluiter K; van Zwet E; van Vliet P; Baas F; Haitsma I; Verbaan D; Coert B; de Ruiter GCW; Moojen WA; van der Jagt M; Peul WC
Trials; 2021 Dec; 22(1):874. PubMed ID: 34863258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
